Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12623000313639
Ethics application status
Approved
Date submitted
9/03/2023
Date registered
22/03/2023
Date last updated
3/04/2024
Date data sharing statement initially provided
22/03/2023
Type of registration
Prospectively registered
Titles & IDs
Public title
Acceptability and Efficacy of Remote Treatment for Social Anxiety Disorder
Query!
Scientific title
A Randomised Controlled Trial of the Acceptability and Efficacy of Remote Cognitive Behavioural Therapy for Social Anxiety Disorder in Adults
Query!
Secondary ID [1]
309127
0
None
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Social Anxiety Disorder
329221
0
Query!
Condition category
Condition code
Mental Health
326181
326181
0
0
Query!
Anxiety
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Those in the immediate treatment condition will receive a manualised cognitive behaviour therapy (CBT) protocol that is informed by the Rapee and Heimberg (1997) model of social anxiety disorder. The treatment will be delivered by internet-videoconferencing. Treatment is delivered one-on-one in 50-minute sessions over an 8 week period. In total, participants will receive 8 sessions as one 50-minute per week. Participants will be asked to complete at-home activities between sessions such as symptom monitoring, problem solving using restructured thoughts, graded exposure. It is anticipated that participants will spend at least 10 minutes per day practicing cognitive restructuring and exposure techniques learned in session.
The treatment will comprise of five modules and will cover the following topics:
Module 1: Psychoeducation (week 1)
Module 2: Challenging automatic thoughts (weeks 2 - 3)
Module 3: Challenging core beliefs (week 4)
Module 4: Exposure (weeks 5 - 7)
Module 5: Relapse prevention/consolidation (week 8)
Treatment will be delivered by provisionally registered psychologists in their final year of a Master of Clinical Psychology degree or a clinical psychology registrar, under the supervision of an experienced clinical psychologist. All treating clinicians will be thoroughly trained in the administration of the treatment protocol by the project investigators and receive weekly supervision. All sessions will be recorded and at least 10% of sessions will be randomly selected for treatment fidelity.
Query!
Intervention code [1]
325576
0
Behaviour
Query!
Intervention code [2]
325706
0
Treatment: Other
Query!
Comparator / control treatment
During the eight-week wait-list period, participants will be asked to refrain from seeking external psychological counselling. Following the eight-week wait-list period, participants in the wait-list control condition will be offered eight weekly, 50-minute sessions of imagery rescripting (ImR) for social anxiety disorder following the protocol established by Wild and Clark (2011). ImR is a collection of imagery techniques that alter negative meanings associated with autobiographical memories of distressing experiences. Treatment is delivered one-on-one in 50-minute sessions over an 8 week period. In total, participants will receive 8 sessions as one 50-minute per week. Participants will be asked to complete at-home activities between sessions such as symptom monitoring. It is anticipated that participants will spend at least 10 minutes per day practicing cognitive restructuring techniques learned in session.
ImR treatment will comprise of four modules and will cover the following topics:
Module 1: Psychoeducation (week 1)
Module 2: Identification and exploration of core beliefs (week 2)
Module 3: Imagery rescripting (weeks 3 - 7)
Module 4: Relapse prevention/consolidation (week 8)
Treatment will be delivered by provisionally registered psychologists in their final year of a Master of Clinical Psychology degree or a clinical psychology registrar, under the supervision of an experienced clinical psychologist. All treating clinicians will be thoroughly trained in the administration of the treatment protocol by the project investigators and receive weekly supervision. All sessions will be recorded and at least 10% of sessions will be randomly selected for treatment fidelity.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
334058
0
Social anxiety disorder symptom severity will be measured with the Social Interaction Anxiety Scale-Short Form (SIAS-6) (Mattick & Clarke, 1998)
Query!
Assessment method [1]
334058
0
Query!
Timepoint [1]
334058
0
Baseline
Mid-treatment (week 4)
Post treatment (week 9, primary endpoint)
3-month follow-up post treatment completion
Query!
Primary outcome [2]
334059
0
Social anxiety disorder symptom severity will be measured with the Social Phobia Scale-Short Form (SPS) (Mattick & Clarke, 1998)
Query!
Assessment method [2]
334059
0
Query!
Timepoint [2]
334059
0
Baseline
Mid-treatment (week 4)
Post treatment (week 9, primary endpoint)
3-month follow-up post treatment completion
Query!
Primary outcome [3]
334105
0
Acceptability will be measured with the Client Satisfaction Questionnaire (CSQ) (Attkisson & Zwick, 1982)
Query!
Assessment method [3]
334105
0
Query!
Timepoint [3]
334105
0
Mid-treatment (week 4)
Post treatment (week 9, primary endpoint)
Query!
Secondary outcome [1]
419206
0
Social anxiety disorder symptom severity will be measured with the Social Anxiety Disorder Dimensional Scale (SAD-D) (LeBeau et al., 2012)
Query!
Assessment method [1]
419206
0
Query!
Timepoint [1]
419206
0
Baseline
Mid-treatment (week 4)
Post treatment (week 9)
3-month follow-up post treatment completion
Query!
Secondary outcome [2]
419207
0
Depression symptom severity will be measured with the Patient Health Questionnaire - 9 item (PHQ-9) (Kroenke et al., 2001)
Query!
Assessment method [2]
419207
0
Query!
Timepoint [2]
419207
0
Baseline
Mid-treatment (week 4)
Post treatment (week 9)
3-month follow-up post treatment completion
Query!
Secondary outcome [3]
419208
0
Social anxiety disorder symptom severity will be measured with the NIMH Clinician Global Impression (CGI) Scale (self-report version) (Guy, 1976)
Query!
Assessment method [3]
419208
0
Query!
Timepoint [3]
419208
0
Baseline
Mid-treatment (week 4)
Post treatment (week 9)
3-month follow-up post treatment completion
Query!
Secondary outcome [4]
419209
0
Disability will be measured with the Sheehan Disability Scale (SDS) (Sheehan, 1983)
Query!
Assessment method [4]
419209
0
Query!
Timepoint [4]
419209
0
Baseline
Mid-treatment (week 4)
Post treatment (week 9)
3-month follow-up post treatment completion
Query!
Secondary outcome [5]
419210
0
Strength of core beliefs will be measured with the Core Beliefs Questionnaire (CBQ) - Trait Version (Wong & Moulds, 2011)
Query!
Assessment method [5]
419210
0
Query!
Timepoint [5]
419210
0
Baseline
Mid-treatment (week 4)
Post treatment (week 9)
3-month follow-up post treatment completion
Query!
Secondary outcome [6]
419211
0
Symptoms of perfectionism will be measured with the Clinical Perfectionism Questionnaire (CPQ) (Fairburn et al., 2003)
Query!
Assessment method [6]
419211
0
Query!
Timepoint [6]
419211
0
Baseline
Mid-treatment (week 4)
Post treatment (week 9)
3-month follow-up post treatment completion
Query!
Secondary outcome [7]
419212
0
Symptoms of shame will be measured with The Experience of Shame Scale (Andrews et al., 2002)
Query!
Assessment method [7]
419212
0
Query!
Timepoint [7]
419212
0
Baseline
Mid-treatment (week 4)
Post treatment (week 9)
3-month follow-up post treatment completion
Query!
Secondary outcome [8]
419213
0
Self-compassion will be measured witih the Self-Compassion Scale-Short Form (SCS-SF) (Raes et al., 2011)
Query!
Assessment method [8]
419213
0
Query!
Timepoint [8]
419213
0
Baseline
Mid-treatment (week 4)
Post treatment (week 9)
3-month follow-up post treatment completion
Query!
Eligibility
Key inclusion criteria
1. Currently resides in Australia
2. Aged 18+ years
3. Fluent in English
4. Meets criteria for social anxiety disorder as primary diagnosis and the disorder is of at least 'moderate severity' (defined as a score of 4 on the DIAMOND module severity measure (Tolin et al., 2018))
5. Medication free or on a stable dose of psychotropic medication
6. Not currently receiving regular psychological services for their social anxiety symptoms (defined as sessions at least once a week with a qualified mental health professional)
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
1. Severe depressive symptoms as assessed by a score of 20 or above on the PHQ-9
2. Are at suicide risk by a score of "2" (more than half the days) or higher on item 9 of the PHQ-9 on the screening questions or via clinician judgement during the interview using the Columbia-Suicide Severity Rating Scale (C-SSRS)
3. Engage in daily alcohol use or daily illicit drug use
4. Presence of schizophrenia spectrum disorder as assessed by the DIAMOND
5. Significant cognitive/intellectual impairment as assessed during the diagnostic interview
6. A medical condition that may interfere with treatment
7. Does not have access to a computer with a camera and stable internet on a regular basis
8. Is not willing to engage in treatment via internet videoconferencing software
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation is not concealed.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Randomization will be conducted by the Chief Investigator using a random number generator
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Participants will be randomly assigned to an immediate treatment group (n = 39) or wait-list control group (n = 39). Group 1 will receive immediate access to eight-session CBT intervention, and Group 2 will receive ImR treatment after an eight-week wait period.
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
3/04/2023
Query!
Actual
20/04/2023
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
78
Query!
Accrual to date
66
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
ACT,NSW,NT,QLD,SA,TAS,WA,VIC
Query!
Funding & Sponsors
Funding source category [1]
313330
0
University
Query!
Name [1]
313330
0
University of Technology Sydney
Query!
Address [1]
313330
0
Discipline of Clinical Psychology, Graduate School of Health, PO Box 123 Broadway, Ultimo, NSW 2007
Query!
Country [1]
313330
0
Australia
Query!
Primary sponsor type
University
Query!
Name
University of Technology Sydney
Query!
Address
Discipline of Clinical Psychology, Graduate School of Health, PO Box 123 Broadway, Ultimo, NSW 2007
Query!
Country
Australia
Query!
Secondary sponsor category [1]
315116
0
None
Query!
Name [1]
315116
0
Query!
Address [1]
315116
0
Query!
Country [1]
315116
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
312552
0
University of Technology Sydney Health and Medical Research Ethics Committee (HMREC)
Query!
Ethics committee address [1]
312552
0
C/- Research Office University of Technology Sydney PO Box 123 Broadway NSW 2007
Query!
Ethics committee country [1]
312552
0
Australia
Query!
Date submitted for ethics approval [1]
312552
0
16/01/2023
Query!
Approval date [1]
312552
0
28/03/2023
Query!
Ethics approval number [1]
312552
0
Query!
Summary
Brief summary
The primary objective of this program of research is to examine the acceptability and efficacy of videoconferencing delivered cognitive behavioural therapy (CBT) for social anxiety disorder. The secondary objective of this research project is to examine the efficacy of an imagery rescripting (ImR) enhanced cognitive behavioural therapy intervention for individuals with social anxiety disorder. It is anticipated that high-intensity videoconferencing delivered CBT will (1) be acceptable to individuals with SAD; (2) result in significant reductions in symptoms of social anxiety compared to waitlist control at post-treatment and follow up; (3) ImR enhanced CBT will result in similar reductions to standard CBT.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
125062
0
A/Prof Bethany Wootton
Query!
Address
125062
0
Discipline of Clinical Psychology. Graduate School of Health. PO Box 123. Broadway. NSW 2007.
Query!
Country
125062
0
Australia
Query!
Phone
125062
0
+61 2 9514 3942
Query!
Fax
125062
0
Query!
Email
125062
0
[email protected]
Query!
Contact person for public queries
Name
125063
0
Bethany Wootton
Query!
Address
125063
0
Discipline of Clinical Psychology. Graduate School of Health. PO Box 123. Broadway. NSW 2007.
Query!
Country
125063
0
Australia
Query!
Phone
125063
0
+61 2 9514 3942
Query!
Fax
125063
0
Query!
Email
125063
0
[email protected]
Query!
Contact person for scientific queries
Name
125064
0
Bethany Wootton
Query!
Address
125064
0
Discipline of Clinical Psychology. Graduate School of Health. PO Box 123. Broadway. NSW 2007.
Query!
Country
125064
0
Australia
Query!
Phone
125064
0
+61 2 9514 3942
Query!
Fax
125064
0
Query!
Email
125064
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Yes
Query!
What data in particular will be shared?
Non-identifiable individual participant data of published results for primary outcome measures.
Query!
When will data be available (start and end dates)?
At the completion of the study and after all relevant manuscripts are published for a period of 5 years.
Query!
Available to whom?
Any academic who has expertise in the field of social anxiety disorder.
Query!
Available for what types of analyses?
Any
Query!
How or where can data be obtained?
From the Chief Investigator (
[email protected]
)
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Doc. No.
Type
Citation
Link
Email
Other Details
Attachment
18494
Study protocol
Study protocol will be available on ethics approva...
[
More Details
]
385501-(Uploaded-01-04-2023-18-54-46)-Study-related document.docx
18495
Informed consent form
Informed consent form will be available on ethics ...
[
More Details
]
385501-(Uploaded-01-04-2023-18-56-15)-Study-related document.doc
18496
Ethical approval
Ethics approval will be available once received.
385501-(Uploaded-01-04-2023-18-57-41)-Study-related document.pdf
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
Source
Title
Year of Publication
DOI
Embase
Internet videoconferencing delivered cognitive behavioral therapy for social anxiety disoder: Protocol for a randomized controlled trial.
2023
https://dx.doi.org/10.1016/j.cct.2023.107298
N.B. These documents automatically identified may not have been verified by the study sponsor.
Download to PDF